As part of the Biden Administration's Cancer Moonshot initiative, First Lady Jill Biden and Queen Letizia of Spain visited Columbia University's cancer center on Sept. 21.
Study findings not only show that these mutations can contribute to diffuse large B cell lymphoma, but they identify an approach that should be useful for the analysis of other types of tumors.
Angela Christiano's groundbreaking research in alopecia areata led to the first FDA-approved systemic treatment for the autoimmune disease, and could also point the way to new cancer therapies.
Dr. Ben Izar and collaborators have completed one of the most comprehensive studies of the cells inside melanoma brain metastases, uncovering details that could spur development of novel therapies.
A new study by Iok In Christine Chio, PhD, provides key insights towards a possible treatment that can toggle this molecular switch to block the spread of pancreatic cancer to other organs.
A study, led by Dr. Dawn Hershman, tested whether standing orders embedded in electronic medical records systems could improve prescribing practice for CSFs and lower incidence of febrile neutropenia.
Congratulations to Dr. Benjamin Izar, a recipient of the Schaefer Research Scholar award, supporting his work in drug resistance and novel immunotherapies.
Researchers have developed a multi-organ chip, a novel platform that captures the biology of organ interactions in the body, enabling a new way to study disease progression and treatments.